NumFin

ChromoGenics AB

Sümbol: CHRO.ST

STO

7

SEK

Turuhind täna

  • -0.4925

    P/E suhe

  • 0.0000

    PEG suhe

  • 28.87M

    MRK Cap

  • 0.00%

    DIV tootlus

ChromoGenics AB (CHRO-ST) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete ChromoGenics AB (CHRO.ST) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes ChromoGenics AB fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

07.924.118.9
93.4
24.9
7.5
38.5
8.5
10.9
34.9

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

011.711.713.7
8.7
15.8
3.4
2
0
0
0

balance-sheet.row.inventory

010.210.211
8.2
6.7
7.4
6.1
0
1.1
0

balance-sheet.row.other-current-assets

090.12.2
1.1
2.6
10.6
7.9
0
2.4
2.1

balance-sheet.row.total-current-assets

029.84645.7
111.4
50
25.5
52.5
11
14.5
37

balance-sheet.row.property-plant-equipment-net

098.3103101.8
90.8
74.3
9.5
8.8
10.7
13.7
3.2

balance-sheet.row.goodwill

000.61.5
2.4
3.3
4.2
0
0
0
0

balance-sheet.row.intangible-assets

010.711.79
4.4
4.4
7.5
10.1
13.1
0
0

balance-sheet.row.goodwill-and-intangible-assets

010.712.310.5
6.9
7.7
11.7
10.1
13.1
16.8
17.9

balance-sheet.row.long-term-investments

00.40.40
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0-0.400
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

00.4-0.32.5
4.8
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

0109.4115.5114.8
102.5
82
21.2
18.9
23.8
30.6
21.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0139.2161.5160.4
213.8
132.1
46.7
71.4
34.7
45
58.1

balance-sheet.row.account-payables

02.88.67.8
8.1
18.5
5.3
7.4
2.1
1.7
3.2

balance-sheet.row.short-term-debt

00.20.315.4
0
1.8
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0.3
0.3
0.1
0
0
0

balance-sheet.row.long-term-debt-total

066.663.846.3
57
47.8
49.3
49.3
49.7
49.7
42.2

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

024.415.93.4
21.4
9.6
31.9
7.2
19
4.2
4.8

balance-sheet.row.total-non-current-liabilities

066.666.250.1
63.4
47.8
49.3
49.3
49.7
49.7
42.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0

balance-sheet.row.total-liab

09491102.7
92.9
89.4
86.6
63.9
70.7
55.5
50.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0

balance-sheet.row.common-stock

035.128.73.4
3.4
80.5
8.6
4.6
1.9
26.5
11.2

balance-sheet.row.retained-earnings

0-715.4-661.1-601.7
-534.3
-470.8
-393
-319
-261.8
-237.6
-211.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

09.98.15.6
1.8
0.7
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0713.2694.8650.3
650
432.2
344.4
321.9
223.9
200.5
208

balance-sheet.row.total-stockholders-equity

042.870.557.7
120.9
42.6
-39.9
7.5
-36
-10.5
7.9

balance-sheet.row.total-liabilities-and-stockholders-equity

0139.2161.5160.4
213.8
132.1
46.7
71.4
34.7
45
58.1

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0

balance-sheet.row.total-equity

042.870.557.7
120.9
42.6
-39.9
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-

Total Investments

00.40.42.5
4.8
0
0
0
0
0
0

balance-sheet.row.total-debt

066.864.161.7
57
47.8
49.3
49.3
49.7
49.7
42.2

balance-sheet.row.net-debt

058.94042.8
-36.4
22.9
41.8
10.9
41.2
38.8
7.3

Rahavoogude aruanne

ChromoGenics AB finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

cash-flows.row.net-income

0-52.5-55.9-59.7
-56.8
-74.9
-72
-57
-49.3
-43.5
-32

cash-flows.row.depreciation-and-amortization

04.53.42.3
5
7.9
6.5
6.2
7.3
5.2
4.4

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

04.5-5.82.5
6.2
8.4
4.1
-4.4
2.3
-3.6
2.6

cash-flows.row.account-receivables

00.16.1-3.8
8.7
-8.1
0
0
0
0
0

cash-flows.row.inventory

000.8-2.8
-1.5
0.7
-1.3
-6.1
1.1
-1.1
0

cash-flows.row.account-payables

0-5.80.8-0.4
-13.4
15.7
0
0
0
0
0

cash-flows.row.other-working-capital

010.3-13.69.4
12.4
0.1
5.4
1.7
1.1
-2.5
0

cash-flows.row.other-non-cash-items

02.7-0.9-3.9
-4.1
-3
-1.4
-0.2
-0.2
-0.9
-13.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.1-4.9-16
-20.7
-69
-6.4
-1.3
-0.5
-13.9
-0.8

cash-flows.row.acquisitions-net

0000
0
0.1
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0.4
0
0
0.2
0

cash-flows.row.net-cash-used-for-investing-activites

0-0.1-4.9-16
-20.6
-68.8
-6
-1.3
-0.5
-13.7
-0.8

cash-flows.row.debt-repayment

00-0.3-0.1
-1.9
-12.7
0
0
0
0
-0.6

cash-flows.row.common-stock-issued

024.869.80.3
140.8
160.4
25.2
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0069.50.2
138.9
147.7
12.6
86.7
38
32.6
18.8

cash-flows.row.net-cash-used-provided-by-financing-activities

024.869.50.2
138.9
147.7
37.8
86.7
38
32.6
18.1

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-16.25.3-74.5
68.5
17.3
-30.9
29.9
-2.4
-24
-21.4

cash-flows.row.cash-at-end-of-period

07.924.118.9
93.4
24.9
7.5
38.5
8.5
10.9
34.9

cash-flows.row.cash-at-beginning-of-period

024.118.993.4
24.9
7.5
38.5
8.5
10.9
34.9
56.3

cash-flows.row.operating-cash-flow

0-40.8-59.3-58.8
-49.7
-61.6
-62.8
-55.5
-39.9
-42.9
-38.7

cash-flows.row.capital-expenditure

0-0.1-4.9-16
-20.7
-69
-6.4
-1.3
-0.5
-13.9
-0.8

cash-flows.row.free-cash-flow

0-41-64.2-74.7
-70.4
-130.5
-69.2
-56.8
-40.4
-56.8
-39.6

Kasumiaruande rida

ChromoGenics AB tulud muutusid võrreldes eelmise perioodiga NaN%. CHRO.ST brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

income-statement-row.row.total-revenue

013.618.324.7
14.6
45.2
11.2
6.9
3
0
0

income-statement-row.row.cost-of-revenue

064.31515.9
14.5
48.5
33.4
29.4
15
0
0

income-statement-row.row.gross-profit

0-50.63.38.7
0.1
-3.2
-22.2
-22.5
-11.9
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

002925.1
30.2
34.8
0
-0.1
0
-0.2
0

income-statement-row.row.operating-expenses

055.860.869.6
57.5
73.2
50.2
34.6
37.8
43.5
32

income-statement-row.row.cost-and-expenses

064.375.885.6
72
121.6
83.7
64
52.8
43.5
32

income-statement-row.row.interest-income

00.50.60.1
0.1
0
0
0
0
0
0.2

income-statement-row.row.interest-expense

04.31.74
5.8
3
1.4
0.2
0.2
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.90.6-2.7
-5.1
-3
-1
-0.1
0.2
0
0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

002925.1
30.2
34.8
0
-0.1
0
-0.2
0

income-statement-row.row.total-operating-expenses

0-1.90.6-2.7
-5.1
-3
-1
-0.1
0.2
0
0.2

income-statement-row.row.interest-expense

04.31.74
5.8
3
1.4
0.2
0.2
0
0

income-statement-row.row.depreciation-and-amortization

04.553.4
5.5
7.8
6.5
6.2
7.3
5.2
4.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-50.6-57.5-60.9
-57.4
-74.9
-72
-57
-49.3
-43.5
-32

income-statement-row.row.income-before-tax

0-52.5-57-63.5
-62.5
-77.9
-73.4
-57.2
-49.5
-43.5
-31.8

income-statement-row.row.income-tax-expense

00-0.63.8
5.6
2.8
0.4
0.1
0.1
0
0.2

income-statement-row.row.net-income

0-52.5-56.4-67.3
-68.1
-80.7
-73.4
-57.2
-49.5
-43.5
-31.8
Sarnased aktsiad
Sind võib huvitada ka:
003012.SZ
Guangdong Dongpeng Holdings Co., Ltd..
7.52 CNY
SHZ
BURCB
Burnham Holdings, Inc..
13.3 USD
PNK
KGP.L
Kingspan Group plc.
72.8 EUR
LSE
UPIPF
Universal PropTech Inc..
0.0258 USD
PNK
24CS.BK
Twenty - Four Con & Supply Public Company Limited.
1.42 THB
SET
SCWTF
Schweiter Technologies AG.
768.66 USD
PNK
JSGRY
LIXIL Corporation.
26.15 USD
PNK
KGSPF
Kingspan Group plc.
75 USD
PNK
VLUTF
Volution Group plc.
4.6 USD
PNK
SNWAF
Sanwa Holdings Corporation.
15.17 USD
PNK

Korduma kippuv küsimus

Mis on ChromoGenics AB (CHRO.ST) koguvara?

ChromoGenics AB (CHRO.ST) koguvara on 139163000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on -0.745.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -10.337.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -3.912.

Mis on ettevõtte kogutulu?

Kogutulu on -3.675.

Mis on ChromoGenics AB (CHRO.ST) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -52506000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 66819999.000.

Mis on tegevuskulude arv?

Tegevuskulud on 55824000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.